Published in Ann R Coll Surg Engl on August 01, 1974
Diverticular disease of the colon: a deficiency disease of Western civilization. Br Med J (1971) 9.82
Unprocessed bran in treatment of diverticular disease of the colon. Br Med J (1972) 3.72
Sigmoid Myotomy [Abridged]. Proc R Soc Med (1964) 3.60
Diverticulitis: a follow-up of 100 cases. Br Med J (1966) 2.15
REVISED CONCEPTS ON DIVERTICULAR DISEASE OF THE COLON. I. DIVERTICULOSIS: EMPHASIS ON TISSUE DERANGEMENT AND ITS RELATION TO THE IRRITABLE COLON SYNDROME. Radiology (1964) 2.04
THE MUSCLE ABNORMALITY IN DIVERTICULAR DISEASE OF THE COLON. Proc R Soc Med (1963) 2.03
Mass movements (mass peristalsis) and diverticular disease OF THE COLON. Br J Radiol (1967) 1.70
Rectal and colonic studies after resection of the sigmoid for diverticular disease. Gut (1970) 1.39
Effect of methylcellulose on rectal and colonic pressures in treatment of diverticular disease. Br Med J (1972) 1.36
A study of abnormal muscular patterns in diverticular disease of the colon using the polysiloxane foam enema. Gut (1970) 1.22
A Demonstration ON DIVERTICULA OF THE ALIMENTARY TRACT OF CONGENITAL OR OF OBSCURE ORIGIN: Given at the Royal College of Surgeons, England. Br Med J (1910) 1.13
Diverticular disease of the colon. Clinical aspects. Br J Surg (1969) 1.06
Bowel muscle in diverticular disease. Gut (1966) 1.03
Diverticular disease of the large intestine. Ann R Coll Surg Engl (1973) 0.86
Management of uncomplicated diverticular disease by colonic resection in patients at St. Mark's Hospital, 1964-9. Br J Surg (1973) 0.86
Transverse taeniomyotomy for diverticular disease. Dis Colon Rectum (1973) 0.85
Diverticulosis of the colon and diet. Br Med J (1969) 0.82
Clinical and manometric results one year after sigmoid myotomy for diverticular disease. Br J Surg (1969) 0.80
Recurrence of high intracolonic pressure following sigmoid myotomy. Br J Surg (1971) 0.79
The effect of transverse section of the taeniae coli (taeniamyotomy) on intracolonic pressures in the rabbit. Scand J Gastroenterol (1972) 0.78
Sigmoid myotomy with peritoneal graft. Proc R Soc Med (1969) 0.78
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
Monarch Bt-corn paper questioned. Nat Biotechnol (1999) 3.23
Conventional tissue culture compared with rapid immunofluorescence for identifying Chlamydia trachomatis in specimens from patients attending a genitourinary clinic. Genitourin Med (1985) 2.54
Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain (2003) 2.24
Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis. Brain (2004) 2.23
Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer (2009) 2.18
Effects of a minor isoleucyl tRNA on heterologous protein translation in Escherichia coli. J Bacteriol (1995) 2.14
Chlamydial serology in fertile and infertile women. Lancet (1984) 2.10
Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08
DNA chips: an array of possibilities. Nat Biotechnol (1998) 1.95
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med (1983) 1.89
The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother (1997) 1.62
No consistent effect of plant diversity on productivity. Science (2000) 1.52
The distribution of polycomb-group proteins during cell division and development in Drosophila embryos: impact on models for silencing. J Cell Biol (1998) 1.46
Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol (1982) 1.43
Effect of methylcellulose on rectal and colonic pressures in treatment of diverticular disease. Br Med J (1972) 1.36
Human papovavirus in Papanicolaou smears of urinary sediment detected by transmission electron microscopy. J Clin Pathol (1977) 1.31
A comparison of Rubazyme-M and MACRIA for the detection of rubella-specific IgM. J Virol Methods (1984) 1.21
Children who are seen but not referred: hearing assessment after bacterial meningitis. Br J Audiol (1993) 1.15
RAE28, BMI1, and M33 are members of heterogeneous multimeric mammalian Polycomb group complexes. Biochem Biophys Res Commun (1998) 1.14
The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen. J Immunol (1990) 0.99
Analysts, firms pour cold water on SNP Consortium. Nat Biotechnol (1999) 0.97
Observation of two-neutrino double-beta decay in 136Xe with the EXO-200 detector. Phys Rev Lett (2011) 0.97
Evaluation of a commercial antibody capture enzyme immunoassay for the detection of rubella specific IgM. J Clin Pathol (1984) 0.96
Hepatitis and haemophilia therapy in Australia. Lancet (1982) 0.96
Remodeling MMPIs. Biotechnology (N Y) (1995) 0.95
New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective. JAMA (1996) 0.95
To treat or not to treat: that is the question for serum. Biotechnology (N Y) (1995) 0.93
Pharmacogenomics: will the regulators approve? Nat Biotechnol (1998) 0.92
The detection of rubella-specific IgM by an immunosorbent assay with solid-phase attachment of red cells (SPARC). J Hyg (Lond) (1982) 0.92
Differential induction of programmed cell death in CD8+ and CD4+ T cells by the B subunit of cholera toxin. Cell Immunol (1996) 0.90
Enzyme transfer from pancreas to plasma during acute pancreatitis. The contribution of ascitic fluid and lymphatic drainage of the pancreas. Gut (1985) 0.89
The headache of knowledge management. Nat Biotechnol (2001) 0.88
Data-directed drug design. Biotechnology (N Y) (1991) 0.88
Transformation of 2,4,6-trinitrotoluene (TNT) by immobilized Phanerochaete chrysosporium under fed-batch and continuous TNT feeding conditions. Biotechnol Bioeng (2001) 0.87
Effects of physical conditioning on cardiorespiratory function, body composition and serum lipids in relatively normal-weight and obese middle-aged women. Int J Obes (1979) 0.86
Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists. J Med Chem (1996) 0.86
Age-related greater Achilles tendon compliance is not associated with larger plantar flexor muscle fascicle strains in senior women. J Appl Physiol (1985) (2014) 0.86
Transverse taeniomyotomy for diverticular disease. Dis Colon Rectum (1973) 0.85
Checking sources: the serum supply secret. Biotechnology (N Y) (1991) 0.84
Rhinoplasty: the light reflexes. Plast Reconstr Surg (1990) 0.84
The control of herbage intake in the grazing ruminant. Proc Nutr Soc (1985) 0.84
Pharmaceutical screening: from off-the-wall to off-the-shelf. The many routes to successful drug discovery. Biotechnology (N Y) (1993) 0.83
Ornithine decarboxylase activity in uninfected and vaccinia virus-infected HeLa cells. Biochem Biophys Res Commun (1975) 0.83
Molecular evaluation of enteroviruses in the pathogenesis of idiopathic dilated cardiomyopathy. Clin Cardiol (1997) 0.83
Still waters run deep. Biotechnology (N Y) (1994) 0.83
National politicians block GM progress. Nat Biotechnol (2000) 0.83
Fetal bovine serum revisited. A year ago serum regulations were a hodgepodge. Has anything changed? Biotechnology (N Y) (1993) 0.82
Mortality from asbestosis and mesothelioma in Britain by birth cohort. Occup Med (Lond) (2012) 0.82
Clinically apparent rubella reinfection. J Infect (1984) 0.82
A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies. J Immunother (1999) 0.82
Effect of the in vivo priming regimen for peripheral blood stem cells (PBSC) mobilization on in vitro generation of cytotoxic effectors by IL-2 activation of PBSC in a murine model. Bone Marrow Transplant (1997) 0.80
Effect of plant species on the larvae of gastrointestinal nematodes which parasitise sheep. Int J Parasitol (1998) 0.80
First genetic trust banks on genes. Nat Biotechnol (2000) 0.80
Absence of AIDS in haemophiliacs in Australia treated from an entirely voluntary blood donor system. Lancet (1983) 0.79
Expression systems: a user's guide. Emphasis has shifted from the vector construct to the host organism. Biotechnology (N Y) (1993) 0.79
The changing bulk biocatalyst market. Biotechnology (N Y) (1994) 0.79
Diverticular disease. Possible correlation between low residue diet and raised intracolonic pressures in the rabbit model. Am J Gastroenterol (1974) 0.79
Acquired aphasia without deafness in childhood--the Landau-Kleffner syndrome. J Laryngol Otol (1993) 0.78
Showers in raincoats: attitudinal barriers to condom use in high-risk heterosexuals. Community Health Stud (1988) 0.78
No evidence of endemic Borna disease virus infection in Australian horses in contrast with endemic infection in other continents. Arch Virol (2005) 0.78
Ankle morphology amplifies calcaneus movement relative to triceps surae muscle shortening. J Appl Physiol (1985) (2013) 0.78
LION and Degussa apply genomics to fermentation. Nat Biotechnol (1998) 0.78
Centrifugation takes a new turn. Biotechnology (N Y) (1991) 0.77
Relationship between percent maximal O2 uptake and percent maximal heart rate in women. Res Q Exerc Sport (1980) 0.77
Light, angles, action. Instruments for label-free, real-time monitoring of intermolecular interactions. Biotechnology (N Y) (1994) 0.77
A model for peer experiential and reciprocal supervision (PEERS) for genetic counselors: development and preliminary evaluation within clinical practice. J Genet Couns (2012) 0.77
Animal models in the study of diverticular disease. Part I: aetiology and treatment. Clin Gastroenterol (1975) 0.77
Controlling internal parasites in grazing ruminants without recourse to anthelmintics: approaches, experiences and prospects. Int J Parasitol (1997) 0.77
Protein design: rules, empiricism, & nature. Biotechnology (N Y) (1990) 0.77
Immune recognition of influenza virus haemagglutinin. Philos Trans R Soc Lond B Biol Sci (1989) 0.76
Variation in condensed tannin concentration of a temperate grass (Holcus lanatus) in relation to season and reproductive development. J Chem Ecol (1995) 0.76
Shrinking DNA diagnostics to fill the markets of the future. Nat Biotechnol (1998) 0.76
All clear for HIV-targeting ribozyme in phase II. Nat Biotechnol (1998) 0.76
Rational design of high affinity tachykinin NK2 receptor antagonists. Bioorg Med Chem (1994) 0.75
Public Health Laboratory Service IgM antibody capture enzyme linked immunosorbent assay for detecting rubella specific IgM. J Clin Pathol (1985) 0.75
Hearing assessment after meningitis and meningococcal disease. Arch Dis Child (1995) 0.75
You may get an offer you can't refuse. Ann R Coll Surg Engl (1975) 0.75
Enteroviral pharyngitis diagnosed by reverse transcriptase-polymerase chain reaction. Arch Dis Child (1996) 0.75
Curagen lays down markers, 120,000 of them. Nat Biotechnol (1999) 0.75
Moratorium hits Danish companies. Nat Biotechnol (2000) 0.75
Biosafety rules get thumbs up. Nat Biotechnol (2000) 0.75
EU food agency circles round biotech. Nat Biotechnol (1999) 0.75
European biotechnology governance seizes up. Nat Biotechnol (1999) 0.75
Fallout from the merger that might be. Nat Biotechnol (1999) 0.75
GMO roundup. Nat Biotechnol (1999) 0.75
A genetic heritage betrayed or empowered? Nat Biotechnol (1998) 0.75
Scientists avert new GMO crisis. Nat Biotechnol (2000) 0.75
Johnson & Johnson acquires Centocor. Nat Biotechnol (1999) 0.75
Celltech, Chiroscience fire merger gun. Nat Biotechnol (1999) 0.75
Crystal gazing the new biotechnologies. Nat Biotechnol (2000) 0.75
Public biotech 99: the numbers. Nat Biotechnol (2000) 0.75
Patent case unblocks antibody businesses. Nat Biotechnol (1999) 0.75
EC struggles to unravel regulations. Nat Biotechnol (2000) 0.75
UK interest groups take all sides of GM issue. Nat Biotechnol (1999) 0.75
Validating a business model. Nat Biotechnol (2000) 0.75
deCODE looks forward as database law passes. Nat Biotechnol (1999) 0.75
Traders predict biodiversity turmoil. Nat Biotechnol (2000) 0.75
Trimmed down Chiron pitches cancer genomics. Nat Biotechnol (1998) 0.75
EC says 1% is acceptable GMO "contamination". Nat Biotechnol (1999) 0.75